4-(5-((2-Chloroethyl)(2-((2,3-dihydroxypropyl)thio)ethyl)amino)-1-methyl-1H-benzo(d)imidazol-2-yl)butanoic acid
Bendamustine Impurity 29 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Bendamustine Impurity 29 for method validation Bendamustine Impurity 29 reference standard Bendamustine Impurity 29 for ANDA filing Bendamustine Impurity 29 for forced degradation studies Bendamustine Impurity 29 identification standard Bendamustine Impurity 29 for DMF filing Bendamustine Impurity 29 HPLC standard Bendamustine Impurity 29 supplier Bendamustine Impurity 29 manufacturer Bendamustine Impurity 29 distributor
